These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34229038)

  • 1. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
    Younossi ZM; Ong JP; Takahashi H; Yilmaz Y; Eguc Hi Y; El Kassas M; Buti M; Diago M; Zheng MH; Fan JG; Yu ML; Wai-Sun Wong V; Alswat K; Chan WK; Mendez-Sanchez N; Burra P; Bugianesi E; Duseja AK; George J; Papatheodoridis GV; Saeed H; Castera L; Arrese M; Kugelmas M; Romero-Gomez M; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1456-e1468. PubMed ID: 34229038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of physicians' knowledge about pediatric nonalcoholic fatty liver disease in China.
    Gao XY; Yang YF; Li L; Xing YF; Wang YX; Li XY; Yang SH; Wang MY; Fan JG; Wang H
    J Dig Dis; 2024 Jun; 25(6):380-393. PubMed ID: 38992957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region.
    Alqahtani SA; Yilmaz Y; El-Kassas M; Alswat K; Mawardi M; Sanai FM; Abaakhail F; Alghamdi S; Al-Hamoudi WK; Nader F; Stepanova M; Younossi ZM;
    Ann Hepatol; 2024 Sep; 30(1):101569. PubMed ID: 39276988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
    Younossi ZM; Alqahtani SA; Alswat K; Yilmaz Y; Keklikkiran C; Funuyet-Salas J; Romero-Gómez M; Fan JG; Zheng MH; El-Kassas M; Castera L; Liu CJ; Wai-Sun Wong V; Zelber-Sagi S; Allen AM; Lam B; Treeprasertsuk S; Hameed S; Takahashi H; Kawaguchi T; Schattenberg JM; Duseja A; Newsome PN; Francque S; Spearman CW; Castellanos Fernández MI; Burra P; Roberts SK; Chan WK; Arrese M; Silva M; Rinella M; Singal AK; Gordon S; Fuchs M; Alkhouri N; Cusi K; Loomba R; Ranagan J; Eskridge W; Kautz A; Ong JP; Kugelmas M; Eguchi Y; Diago M; Yu ML; Gerber L; Fornaresio L; Nader F; Henry L; Racila A; Golabi P; Stepanova M; Carrieri P; Lazarus JV;
    J Hepatol; 2024 Mar; 80(3):419-430. PubMed ID: 37984709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH survey.
    Driessen S; de Jong VD; van Son KC; Klompenhouwer T; Colardelle Y; Alings M; Moreno C; Anker SD; Castro Cabezas M; Holleboom AG; Grobbee DE; Tushuizen ME
    United European Gastroenterol J; 2023 Sep; 11(7):654-662. PubMed ID: 37563849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
    Younossi ZM; Yilmaz Y; Yu ML; Wai-Sun Wong V; Fernandez MC; Isakov VA; Duseja AK; Mendez-Sanchez N; Eguchi Y; Bugianesi E; Burra P; George J; Fan JG; Papatheodoridis GV; Chan WK; Alswat K; Saeed HS; Singal AK; Romero-Gomez M; Gordon SC; Roberts SK; El Kassas M; Kugelmas M; Ong JP; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2296-2306.e6. PubMed ID: 34768009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
    Nadolsky K; Cryer DR; Articolo A; Fisher T; Schneider J; Rinella M
    Ann Med; 2023 Dec; 55(1):2211349. PubMed ID: 37171239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatologists' Awareness and Knowledge of NAFLD and the Familiarity with Renaming NAFLD to MAFLD.
    Alem SA; Fouad Y; AbdAllah M; Attia D; Kamal I; Said E; Gomaa A; Abd-Elsalam SM; Gaber Y
    Endocr Metab Immune Disord Drug Targets; 2024; 24(12):1445-1453. PubMed ID: 36306455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease.
    Arab JP; Dirchwolf M; Álvares-da-Silva MR; Barrera F; Benítez C; Castellanos-Fernandez M; Castro-Narro G; Chavez-Tapia N; Chiodi D; Cotrim H; Cusi K; de Oliveira CPMS; Díaz J; Fassio E; Gerona S; Girala M; Hernandez N; Marciano S; Masson W; Méndez-Sánchez N; Leite N; Lozano A; Padilla M; Panduro A; Paraná R; Parise E; Perez M; Poniachik J; Restrepo JC; Ruf A; Silva M; Tagle M; Tapias M; Torres K; Vilar-Gomez E; Costa Gil JE; Gadano A; Arrese M
    Ann Hepatol; 2020; 19(6):674-690. PubMed ID: 33031970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare practitioners' diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey.
    Hartleb M; Mastalerz-Migas A; Kowalski P; Okopień B; Popovic B; Proga K; Cywińska-Durczak B
    Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):426-434. PubMed ID: 34560694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care practitioners survey of non-alcoholic fatty liver disease.
    Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
    Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians.
    Kallman JB; Arsalla A; Park V; Dhungel S; Bhatia P; Haddad D; Wheeler A; Younossi ZM
    Aliment Pharmacol Ther; 2009 May; 29(9):1019-24. PubMed ID: 19220207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
    Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
    Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of nonalcoholic fatty liver disease in the Middle East.
    Sanai FM; Abaalkhail F; Hasan F; Farooqi MH; Nahdi NA; Younossi ZM
    World J Gastroenterol; 2020 Jul; 26(25):3528-3541. PubMed ID: 32742124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
    Islam KB; Brandman D; Chu JN; Goldman ML; Fox RK
    Dig Dis Sci; 2023 Feb; 68(2):434-438. PubMed ID: 36178567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study.
    Ge X; Zheng L; Wang M; Du Y; Jiang J
    BMJ Open; 2020 Aug; 10(8):e036663. PubMed ID: 32747349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region.
    Ong J; Alswat K; Hamid S; El-Kassas M
    Clin Liver Dis; 2023 May; 27(2):287-299. PubMed ID: 37024208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.
    Golabi P; Paik JM; AlQahtani S; Younossi Y; Tuncer G; Younossi ZM
    J Hepatol; 2021 Oct; 75(4):795-809. PubMed ID: 34081959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
    Polanco-Briceno S; Glass D; Stuntz M; Caze A
    BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.
    Wieland AC; Quallick M; Truesdale A; Mettler P; Bambha KM
    Dig Dis Sci; 2013 Oct; 58(10):2809-16. PubMed ID: 23843097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.